VSL has completed a major letting to leading artificial intelligence (AI)-driven pharmatech company Exscientia at Milton Park, Oxford.
Founded in 2012, Exscientia utilises AI-led technology to discover and design medicines and treatments faster and more efficiently than through conventional methods.
Exscientia’s expansion will see the firm occupy 20,151 sq ft of laboratory and office space at 155 Brook Drive, Milton Park which is part of the Science Vale Enterprise Zone.
Andrew Hopkins, CEO, Exscientia, said: “We’re delighted to have chosen Milton Park for new laboratories as part of the next stage of our business growth. This new, state-of-the-art space is the ideal location for Exscientia as we bring more highly-skilled people into the business with the ability to deploy and continue to develop innovative technology to create new medicines and treatments faster and more efficiently, benefitting patients worldwide.”
Richard Venables, director at VSL said: “We are pleased to have secured another premises for Exscientia which more than doubles its footprint to over 47,000 sq ft in Oxfordshire. In 2018 we acquired its head office facilities in The Schrödinger Building on The Oxford Science Park and this expansion will create a further 100 new jobs in Oxfordshire building on more than 100 employees already added in 2021.”
“The new facility will increase Exscientia’s capacity and efficiency of leading AI-based drug discovery capabilities through investment in additional automation of chemistry and biology. This deal further underpins the current momentum of emerging growth within the science and technology sector which is the real driver of the Oxfordshire economy at present.”
Tom Booker, Commercial Manager, MEPC Milton Park, said: “Providing spaces for life sciences companies at the forefront of innovation is at the heart of what we do at Milton Park, so we’re absolutely delighted to offer a site to Exscientia as their plans for growth come to life.
“Exscientia’s pioneering use of AI technology to make the discovery of medicines more efficient is perhaps more pertinent than ever in light of COVID-19. We’re very pleased to welcome Exscientia to the Milton Park community at what is an exciting point in their evolution.”
Exscientia is a global company, headquartered in Oxford, UK with sites in Miami, Vienna, Dundee and Osaka. The company currently has over 170 people, roughly split between technologists and drug discovery scientists, with a united goal to find smarter and faster ways to discover and develop new drugs.
VSL’s annual Oxfordshire market reports.View the market reports
We offer a wide range of services to both landlords and tenants.View our Services
Our clients benefit from a very personal and approachable service.Meet the team